234 related articles for article (PubMed ID: 37395335)
1. Cancer-associated fibroblast expression of glutamine fructose-6-phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer.
Yang S; Li G; Yin X; Wang Y; Jiang X; Bian X; Fang T; Yin S; Zhang L; Xue Y
J Pathol Clin Res; 2023 Sep; 9(5):391-408. PubMed ID: 37395335
[TBL] [Abstract][Full Text] [Related]
2.
Zhang W; Bouchard G; Yu A; Shafiq M; Jamali M; Shrager JB; Ayers K; Bakr S; Gentles AJ; Diehn M; Quon A; West RB; Nair V; van de Rijn M; Napel S; Plevritis SK
Cancer Res; 2018 Jul; 78(13):3445-3457. PubMed ID: 29760045
[TBL] [Abstract][Full Text] [Related]
3. Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) promotes the EMT of serous ovarian cancer by activating the hexosamine biosynthetic pathway to increase the nuclear location of β-catenin.
Zhou L; Luo M; Cheng LJ; Li RN; Liu B; Linghu H
Pathol Res Pract; 2019 Dec; 215(12):152681. PubMed ID: 31685298
[TBL] [Abstract][Full Text] [Related]
4. Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial-Mesenchymal Transition and Responds to Oxidative Stress.
Wang Q; Karvelsson ST; Kotronoulas A; Gudjonsson T; Halldorsson S; Rolfsson O
Mol Cell Proteomics; 2022 Feb; 21(2):100185. PubMed ID: 34923141
[TBL] [Abstract][Full Text] [Related]
5. Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon Cancer.
Ding X; Liu H; Yuan Y; Zhong Q; Zhong X
Front Oncol; 2022; 12():811559. PubMed ID: 35330716
[TBL] [Abstract][Full Text] [Related]
6. Common variants in glutamine:fructose-6-phosphate amidotransferase 2 (GFPT2) gene are associated with type 2 diabetes, diabetic nephropathy, and increased GFPT2 mRNA levels.
Zhang H; Jia Y; Cooper JJ; Hale T; Zhang Z; Elbein SC
J Clin Endocrinol Metab; 2004 Feb; 89(2):748-55. PubMed ID: 14764791
[TBL] [Abstract][Full Text] [Related]
7. A prognostic marker LTBP1 is associated with epithelial mesenchymal transition and can promote the progression of gastric cancer.
Jiang X; Yin S; Yin X; Wang Y; Fang T; Yang S; Bian X; Li G; Xue Y; Zhang L
Funct Integr Genomics; 2024 Feb; 24(1):30. PubMed ID: 38358412
[TBL] [Abstract][Full Text] [Related]
8. The prognostic marker elastin correlates with epithelial-mesenchymal transition and vimentin-positive fibroblasts in gastric cancer.
Fang T; Zhang L; Yin X; Wang Y; Zhang X; Bian X; Jiang X; Yang S; Xue Y
J Pathol Clin Res; 2023 Jan; 9(1):56-72. PubMed ID: 36226731
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
10. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
11. NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer.
Szymura SJ; Zaemes JP; Allison DF; Clift SH; D'Innocenzi JM; Gray LG; McKenna BD; Morris BB; Bekiranov S; LeGallo RD; Jones DR; Mayo MW
Cell Commun Signal; 2019 Mar; 17(1):24. PubMed ID: 30885209
[TBL] [Abstract][Full Text] [Related]
12. The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer.
Zhang HR; Li TJ; Yu XJ; Liu C; Wu WD; Ye LY; Jin KZ
Cell Death Dis; 2024 Apr; 15(4):244. PubMed ID: 38575607
[TBL] [Abstract][Full Text] [Related]
13. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
14. GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.
Xu W; Jiang T; Shen K; Zhao D; Zhang M; Zhu W; Liu Y; Xu C
Front Endocrinol (Lausanne); 2023; 14():1224832. PubMed ID: 37608794
[TBL] [Abstract][Full Text] [Related]
15. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
16. Targeting GPC3
Li D; Wang Y; Shi C; Fu S; Sun YF; Li C
Ann Med; 2023 Dec; 55(1):2189295. PubMed ID: 37036308
[TBL] [Abstract][Full Text] [Related]
17. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer.
Zhou Z; Guo S; Lai S; Wang T; Du Y; Deng J; Zhang S; Gao G; Zhang J
BMC Cancer; 2023 Jan; 23(1):108. PubMed ID: 36717783
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of cancer-associated fibroblast signature in gastric cancer.
Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C
Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716
[TBL] [Abstract][Full Text] [Related]
19. Construction of a hypoxia-immune-related prognostic panel based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer.
Deng C; Deng G; Chu H; Chen S; Chen X; Li X; He Y; Sun C; Zhang C
Front Immunol; 2023; 14():1140328. PubMed ID: 37180146
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Model and Immune Infiltration of Ferroptosis Subcluster-Related Modular Genes in Gastric Cancer.
Deng H; Lin Y; Gan F; Li B; Mou Z; Qin X; He X; Meng Y
J Oncol; 2022; 2022():5813522. PubMed ID: 36276279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
